Filing Details

Accession Number:
0001179110-19-010157
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-06 16:22:08
Reporting Period:
2019-09-04
Accepted Time:
2019-09-06 16:22:08
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1434868 Esperion Therapeutics Inc. ESPR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1242613 M Timothy Mayleben C/O Esperion Therapeutics, Inc.
3891 Ranchero Drive, Suite 150
Ann Arbor MI 48108
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-09-04 4,852 $34.22 76,015 No 4 P Direct
Common Stock Acquisiton 2019-09-04 148 $33.42 76,163 No 4 P Direct
Common Stock Acquisiton 2019-09-06 2,500 $35.25 78,663 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.77 to $34.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
  2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.35 to $33.45, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.